Previous 10 | Next 10 |
2023-07-02 12:00:52 ET The tables have turned for Contract services organizations (CROs), with their toplines under pressure amid a post-pandemic drop in demand for clinical trial services worsened by biotech’s funding woes. The group offers clinical trial management services for...
New plasmids will help accelerate and standardize lentiviral vector development from clinical to commercial manufacturing Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a st...
Charles River Laboratories International, Inc. (NYSE: CRL) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 3.63% on the day to $204.86. Charles River Laboratories International, Inc., a non-clinical contract resear...
Adenovirus production underpins preclinical trials targeting genes responsible for tumor growth Charles River Laboratories International, Inc. (NYSE: CRL) and Curigin , a Korean biotechnology company developing innovative oncolytic ribonucleic acid interference (RNAi) gene therapies...
CDMO will perform HQ plasmid production in support of Phase I/II clinical trials for Infantile Neuroaxonal Dystrophy Charles River Laboratories International, Inc. (NYSE: CRL) and the INADcure Foundation , a nonprofit organization whose mission is to support the development of treat...
Radnor, Pennsylvania--(Newsfile Corp. - June 6, 2023) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been against Charles River Laboratories International, Inc. ("Charles River") (NYSE: CRL). The action char...
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 43 rd Annual Growth Stock Conference on Tuesday, June 6 th , at 10:00 a.m. CT (11:00 a.m. ET), and at the Jefferies Global Healthcare Conference on Thursday, June 8 th ...
2023-06-01 21:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory PR Newswire RightSource SM is Charles River's insourced, purpose-built lab offering that provides industry-leading expertise conveniently placed within...
RightSource is Charles River’s insourced, purpose-built lab offering that provides industry-leading expertise conveniently placed within a client’s facility Charles River Laboratories International, Inc. (NYSE: CRL) and Wheeler Bio, Inc., a contract development and manufac...
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Charles River Laboratories International Inc. Website:
Agreement establishes Charles River as the preferred partner for Autobahn Labs, leveraging drug discovery and development capabilities to accelerate the translation of academic discoveries into novel therapeutics Under the agreement, Charles River will make an equity investment in Aut...
Charles River Laboratories International, Inc. (NYSE: CRL) will release second-quarter 2024 financial results on Wednesday, August 7 th , before the market opens. A conference call has been scheduled to discuss this information on Wednesday, August 7 th , at 9:00 a.m. ET. Investors wi...
Critical starting material manufacture for therapeutic targeting high unmet need ophthalmology indication Charles River Laboratories International, Inc. (NYSE: CRL) and AAVantgarde today announced a contract development and manufacturing organization (CDMO) agreement to produce Good...